Translational Oncology

Papers
(The H4-Index of Translational Oncology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario1611
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation117
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency109
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma102
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways85
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors80
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma73
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway71
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation68
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma61
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis58
Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue56
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant56
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies54
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer54
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers52
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics51
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells50
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors47
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer46
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate44
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma44
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer42
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation42
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy42
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer42
The double face of cold in cancer41
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification41
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer40
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma39
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma39
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis38
Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]37
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning37
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations36
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data36
FUBP1 in human cancer: Characteristics, functions, and potential applications36
0.16335201263428